Comparison of the Acute Effects of Chest Physiotherapy Methods Applied in Different Positions in Preterm Newborns
therapy
1 other identifier
interventional
60
1 country
1
Brief Summary
Infants in the neonatal intensive care unit (NICU) may be lost due to risks such as being sensitive, frequent exposure to birth complications and being prone to infection. The most common causes of mortality in newborn babies in the world; Complications due to preterm delivery (28%), infections (26%) and perinatal asphyxia (23%) were reported. Respiratory problems are observed in 4-6% of newborns. These problems are also important causes of mortality in the neonatal period. Newborn infants are more likely to have respiratory distress due to difficulties in airway calibration, few collateral airways, flexible chest wall, poor airway stability, and low functional residual capacity.Invasive mechanical ventilation (IMV) is frequently used in the treatment of newborns with respiratory failure. Various ventilation modes and strategies are used to optimize mechanical ventilation and prevent ventilator-induced lung injury. Among the important issues to be considered in newborns connected to mechanical ventilator (MV); Choosing an appropriately sized endotracheal tube to reduce airway resistance and minimize respiratory workload, correct positioning, regular nursing care, chest physiotherapy, sedation-analgesia, and infection prevention are also included.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 18, 2021
CompletedFirst Posted
Study publicly available on registry
September 5, 2021
CompletedStudy Start
First participant enrolled
April 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2024
CompletedSeptember 12, 2025
August 1, 2022
2.3 years
August 18, 2021
September 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (10)
heart rate
heart rate of the preterm newborns
Before starting chest physiotherapy and up to15 minutes after ending therapy
chest X-Ray
chest X-Ray of the preterm newborns
on the 1st day before starting chest physiotherapy session and up to 24 hours after chest physiotherapy session
arterial blood gases
arterial blood gases from the radial artery or from the umbilical catheter in infants with an umbilical catheter
on the 1st day before starting chest physiotherapy session and up to 24 hours after chest physiotherapy session
PaO₂
PaO₂ of the preterm newborns
on the time before starting chest physiotherapy and up to 15 minutes after ending therapy
blood pressure
blood pressure of the preterm newborns
on the time before starting chest physiotherapy and up to15 minutes after ending therapy
respiratory rate
respiratory rate of the preterm newborns
Before starting chest physiotherapy and up to15 minutes after ending therapy
Peep (cm H₂O)
Peep (cm H₂O) of the preterm newborns
on the time before starting chest physiotherapy and up to 15 minutes after ending therapy
Pip (cm H₂O)
Pip (cm H₂O) of the preterm newborns
on the time before starting chest physiotherapy and up to15 minutes after ending therapy
FİO₂ (%/mm Hg)
FİO₂ (%/mm Hg) of the preterm newborns
on the time before starting chest physiotherapy and up to 15 minutes after ending therapy
O₂ Saturation (mmHg) (SpO₂)
O₂ Saturation (mmHg) (SpO₂) of the preterm newborns
on the time before starting chest physiotherapy and up to 15 minutes after ending therapy
Secondary Outcomes (4)
Chest shape and type (barrel/pektusexcavatum..etc)
on the time before starting chest physiotherapy and up to 15 minutes after ending therapy
Respiratory stress
before physiotherapy
the respiratory pattern
on the time before starting chest physiotherapy and up to 15 minutes after ending therapy
Daily nutrition type
on the time before starting chest physiotherapy and up to 24 hours after chest physiotherapy
Study Arms (3)
1/routin medical care and neonatal intensive care unit's daily care
NO INTERVENTIONGroup 1 (n=20) routine medical treatment for newborns on mechanical ventilator respiratory support and CPAP; Appropriate antibiotics given according to the needs of the baby, enteral-parenteral nutrition, oral or nebulizer drugs for softening the secretion, vitamin supplements and routine nursing care will be provided.
2/active chest physiotherapy in modified drainage positions
EXPERIMENTALGroup 2 (n=20) newborns on mechanical ventilator respiratory support and CPAP; A single session of active chest physiotherapy (CP) will be applied using modified drainage positions (avoiding the trendelenburg position, excessive position change and avoiding hand contact in babies younger than 30 weeks or who are sensitive to position change). Active CP in various modified drainage positions; It will consist of percussion and vibration methods with proprioceptive replacement stimulations. After these methods, aspiration will be performed and a suitable position will be given to the lobe that is desired to be ventilated. In addition, these patients will be given routine medical treatment consisting of appropriate antibiotics, enteral-parenteral nutrition, oral or nebulizer drugs for softening the secretion, vitamin supplements and routine nursing care.
3/active chest physiotherapy in prone positions
EXPERIMENTALGroup 3 (n=20) newborns on mechanical ventilator respiratory support and CPAP; a single session of active chest physiotherapy treatment to be applied only in the prone position; Starting with proprioceptive stimulation, percussion and vibration methods will be applied. After these methods, aspiration will be performed and a suitable position will be given to the lobe that is desired to be ventilated. In addition, these patients will be given routine medical treatment consisting of appropriate antibiotics, enteral-parenteral nutrition, oral or nebulizer drugs for softening the secretion, vitamin supplements and routine nursing care.
Interventions
diffferent chest physiotherapy methods
Eligibility Criteria
You may qualify if:
- Preterm newborns born \<37 and \>28 weeks due to MV or CPAP, hospitalized in the NICU and with a voluntary consent form from their families (with segmental lobar collapse as a result of Chest X-Ray, RDS/BPD/HMH/Atelectasis/Pneumonia/ Preterm newborns diagnosed with Chronic Pulmonary Disease or in stable condition with a thick and secretory focus on X-ray)
- First-time infants who have not received any chest physiotherapy program
You may not qualify if:
- Newborn infants who have been unstable in the last 2 days (SpO₂ \<60 mmHg, heart rate, blood pressure, persistent apnea, excessive increases in respiratory rate, tachycardia, nasal wing breathing, cyanosis..etc)
- Newborn infants with rib fracture, hemoptysis, diaphragmatic hernia, pulmonary hemorrhage, pneumothorax
- Those diagnosed with any known heart disease or genetic disease
- Those with osteopenia-osteoporosis or thrombocytopenia
- Infants with any known neurological diagnosis (Abnormal MRI finding, Hydrocephalus, Chiari Malformation, Asphyxia, Periventricular Leukomolacia (PVL), Intraventricular Hemorrhage (IVH), Kernicterius, Hypoxic Ischemic Encephalopathy (HIE), Hydrocephalus)
- Preterm infants weighing \<1000 g
- Infants born with congenital anomaly (Spina Bifida, Arthrogryposis Multiplex Congenita..etc)
- Newborns undergoing any surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sanko Universitylead
Study Sites (1)
Kahramanmaras Sutcu Imam University
Kahramanmaraş, 46100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
hatice Adiguzel, PhD
Kahramanmaras Sutcu Imam University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Proffessor
Study Record Dates
First Submitted
August 18, 2021
First Posted
September 5, 2021
Study Start
April 1, 2022
Primary Completion
July 30, 2024
Study Completion
December 15, 2024
Last Updated
September 12, 2025
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will not share
there is no plan to make individual participant data (IPD) available to other researchers.